MARATTO

article · Suez Canal Veterinary Medicine Journal SCVMJ

Prevalence of Pseudomonas and Vibrio Species in Shellfish with Special Reference to Their Susceptibility to Antibacterial Agents, Toxigenic and Virulent Genes

Abstract

250 samples were randomly taken from the Port-Said markets, 125 from each of the seemingly healthy Om EL-Khloul "Donax trunculus anatinus" and Baclawese "Tartufo di mare" samples. and subjected to bacteriologically, sensitivity to some antibacterial agents and molecular examination. The prevalence of Pseudomonas and Vibrio species from the examined Om EL-Khloul samples were 35/125 (28.00%) and 30/125 (24.00%) respectively, while that of Baclawese were 52/125 (41.60%) and 40/125 (32.00%) respectively. Biochemical and API identification of the isolates revealed that Pseudomonas species were identified as P. aeruginosa, P. putida, and P. florescent. In contrast, Vibrio species were V. parahaemolyticus, V. vulanificus, V. anguillarum, V. alginolyticus, and V. metschnikovil. Serological typing of P. aeruginosa were P. aeruginosa polyvalent III Group E and P. aeruginosa polyvalent III Group F. while V. parahaemolyticus were identified as O3:K6, O4:K68, O4:K6, O1:K25 and O11:K36. Pseudomonas serovar resists the most studied antibacterial except gentamicin, doxycycline, and tobramycin. Most Vibrio serovar resists studied antibacterial but are sensitive to a lesser extent to Amoxicillin, Chloramphenicol, and Norfloxacin. The molecular study showed that 16S rRNA was detected in Pseudomonas and Vibrio species. A study of the virulence and toxigenic genes showed that toxA and oprL genes were detected in Pseudomonas aeruginosa and the recA genes in Vibrio parahaemolyticus.

Research topics

  • Aquaculture disease management and microbiota
  • Vibrio bacteria research studies
  • Identification and Quantification in Food

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/scvmj.2024.335897

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.